Published in J Cell Mol Med on January 23, 2009
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol (2011) 5.59
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol (2012) 1.60
Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health (2014) 1.58
How to evaluate emerging technologies in cervical cancer screening? Int J Cancer (2009) 1.37
HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer (2011) 1.10
Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol (2011) 1.06
Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme. BMJ Open (2014) 0.92
An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection. Biomed Res Int (2014) 0.88
Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology. PLoS One (2011) 0.88
Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance. J Clin Microbiol (2012) 0.83
[Precancerous lesions of the cervix. Biomarkers in cytological diagnosis]. Pathologe (2011) 0.83
Use of HC2 to triage women with borderline and mild dyskaryosis in the UK. Br J Cancer (2011) 0.82
Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study. Med Decis Making (2011) 0.81
Direct human papillomavirus E6 whole-cell enzyme-linked immunosorbent assay for objective measurement of E6 oncoproteins in cytology samples. Clin Vaccine Immunol (2012) 0.79
Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds. J Clin Microbiol (2012) 0.77
Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities. PLoS One (2015) 0.76
Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer. Cancer Cytopathol (2015) 0.75
Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials. PLoS One (2017) 0.75
3q26 amplification is an effective negative triage test for LSIL: a historical prospective study. PLoS One (2012) 0.75
E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective. Ecancermedicalscience (2015) 0.75
5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions. BMC Clin Pathol (2016) 0.75
The Application of Classification and Regression Trees for the Triage of Women for Referral to Colposcopy and the Estimation of Risk for Cervical Intraepithelial Neoplasia: A Study Based on 1625 Cases with Incomplete Data from Molecular Tests. Biomed Res Int (2015) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA (1998) 26.79
Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol (2003) 18.01
The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA (2002) 15.59
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med (1999) 9.40
2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA (2002) 6.55
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst (2001) 6.36
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol (2007) 6.25
Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol (1986) 5.76
Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet (2006) 5.65
Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39
Summing up evidence: one answer is not always enough. Lancet (1998) 4.66
Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst (1999) 3.88
Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (2003) 3.55
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ (2008) 3.45
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.40
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA (1999) 3.37
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst (2004) 3.20
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine (2006) 3.15
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol (2007) 2.97
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA (1994) 2.71
A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 2.60
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst (2005) 2.47
A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol (2003) 2.45
Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol (1998) 2.37
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol (2008) 2.24
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev (2009) 1.82
A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. Am J Clin Pathol (2005) 1.73
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol (2005) 1.70
Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst (2002) 1.68
A 21-year-old woman with atypical squamous cells of undetermined significance. JAMA (2005) 1.67
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer (2002) 1.60
Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ (2001) 1.53
European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer (1993) 1.52
Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol (2003) 1.44
Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear. Int J Cancer (2005) 1.35
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract (1998) 1.27
Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer (2006) 1.20
Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev (2002) 1.19
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer (2007) 1.15
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ (2006) 1.14
High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance. J Pathol (2001) 1.12
Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests. Diagn Cytopathol (2004) 1.07
HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme. Cytopathology (2005) 1.05
Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol (2000) 1.01
Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol (2002) 0.99
Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents. Obstet Gynecol (2005) 0.97
Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears. Obstet Gynecol (2000) 0.96
Evaluation of adjunctive HPV testing by Hybrid Capture II in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy. BMC Infect Dis (2003) 0.95
Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer (2006) 0.95
Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines. Int J Cancer (2005) 0.94
High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age. J Reprod Med (2000) 0.92
Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions. Mol Cancer (2002) 0.89
Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method. Cancer (2006) 0.88
Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol (2003) 0.87
A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand (2005) 0.87
Chapter 14: Role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr (2003) 0.86
Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. Int J Gynecol Cancer (2006) 0.85
Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet Gynecol (2006) 0.83
Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med (2001) 0.82
Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 0.82
International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention. Cancer Lett (2008) 0.80
High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions. Aust N Z J Obstet Gynaecol (2007) 0.80
[Assessment of human papillomavirus testing on liquid-based Cyto-screen system for women with atypical squamous cells of undetermined significance. Effect of age]. Gynecol Obstet Fertil (2006) 0.79
ASC-US and HPV testing in women aged 40 years and over. Diagn Cytopathol (2004) 0.79
Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears. Cancer (2003) 0.79
BSCC terminology conference, koilocytosis and mild dyskaryosis. Cytopathology (2002) 0.79
Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance. Int J Gynecol Cancer (2006) 0.77
Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection? J Cell Mol Med (2008) 0.77
Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy. J Reprod Med (2002) 0.77
The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. Acta Cytol (1992) 0.77
Re: An alternative cost-effectiveness analysis of ThinPrep in the Australian setting. Aust N Z J Obstet Gynaecol (2006) 0.77
Reflex high-risk human papillomavirus testing for women with atypical squamous cells of undetermined significance in cytologic smears: effects since implementation in a large clinical practice. Am J Clin Pathol (2005) 0.76
Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions? Arch Pathol Lab Med (2001) 0.76
Re: Have we resolved how to triage equivocal cervical cytology? J Natl Cancer Inst (2004) 0.76
ASC-US and high-risk HPV testing: performance in daily clinical practice. Diagn Cytopathol (2006) 0.76
Human Papillomavirus testing for the management of low-grade cervical abnormalities in the UK--Influence of age and testing strategy. J Clin Virol (2006) 0.76
Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study. Acta Obstet Gynecol Scand (2003) 0.76
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med (2005) 6.33
Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med (2007) 5.57
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine (2008) 4.82
Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol (2008) 4.30
Should donors be allowed to give broad consent to future biobank research? Lancet Oncol (2006) 4.30
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20
Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol (2002) 4.19
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer (2004) 4.10
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55
Clinicians' gut feeling about serious infections in children: observational study. BMJ (2012) 3.40
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst (2008) 3.24
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst (2004) 3.20
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine (2006) 3.15
The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract (2003) 3.15
Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet (2010) 2.95
Ethical framework for previously collected biobank samples. Nat Biotechnol (2007) 2.81
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet (2010) 2.56
Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care. Br J Gen Pract (2007) 2.48
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. Eur J Gastroenterol Hepatol (2006) 2.47
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol (2005) 2.35
Seroepidemiology of the human polyomaviruses. J Gen Virol (2003) 2.32
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst (2009) 2.32
Serious infections in children: an incidence study in family practice. BMC Fam Pract (2006) 2.29
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. BMJ (2014) 2.27
Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol (2009) 2.21
Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine (2008) 2.09
RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol (2009) 2.06
A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res (2009) 2.06
Hantaviruses: immunology, treatment, and prevention. Viral Immunol (2004) 2.00
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst (2013) 1.99
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect (2011) 1.78
Global proficiency study of human papillomavirus genotyping. J Clin Microbiol (2010) 1.78
VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol (2012) 1.78
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol (2006) 1.77
Ancient papillomavirus-host co-speciation in Felidae. Genome Biol (2007) 1.75
Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis (2007) 1.73
The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol (2003) 1.72
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin (2009) 1.66
A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J Virol (2004) 1.64
Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla? J Virol (2009) 1.62
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol (2008) 1.62
Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J Virol (2006) 1.61
Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol (2011) 1.60
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol (2005) 1.60
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet (2011) 1.58
The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Eur Heart J (2005) 1.58
Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol (2010) 1.57
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol Oncol (2002) 1.56
Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis (2007) 1.54
Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol (2006) 1.53
Tasks performance by registered nurses and care assistants in nursing homes: a quantitative comparison of survey data. Int J Nurs Stud (2007) 1.51
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol (2007) 1.51
Relating increasing hantavirus incidences to the changing climate: the mast connection. Int J Health Geogr (2009) 1.48
High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol (2004) 1.48
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J Virol (2004) 1.48
Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals. J Infect Dis (2001) 1.47
Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden. J Med Virol (2006) 1.47
Animal papillomaviruses. Virology (2013) 1.47
Characterization of a novel P[25],G11 human group a rotavirus. J Clin Microbiol (2005) 1.46
G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1-like genogroup. J Clin Microbiol (2006) 1.46
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology (2013) 1.44
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer (2002) 1.43
Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog (2009) 1.43
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun (2004) 1.42
Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43. J Virol (2006) 1.42
Studies on the use of BD Vacutainer® SST II™ and RST™ in general practice: investigation of artefactual hyperkalaemia. Ann Clin Biochem (2013) 1.42
Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst (2006) 1.42
Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol (2009) 1.40
Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000. J Med Virol (2003) 1.40
Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer (2005) 1.39
Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol (2007) 1.39
[In Process Citation]. Lakartidningen (2015) 1.38
Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol (2011) 1.33
Signs and symptoms in diagnosing acute myocardial infarction and acute coronary syndrome: a diagnostic meta-analysis. Br J Gen Pract (2008) 1.33
The denominator in general practice, a new approach from the Intego database. Fam Pract (2005) 1.32
Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer (2006) 1.31
Genotype constellation and evolution of group A rotaviruses infecting humans. Curr Opin Virol (2012) 1.29
Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine (2010) 1.28